文献速递消化系统肿瘤

人工神经网络多组学分类在肝胰胆癌中的应用探索

Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data.
PubMed 文献 · Eur J Cancer · 2021-03-26

该研究利用TCGA全外显子测序数据训练人工神经网络(ANN),预测肝胰胆癌的解剖部位、iClusters及分子亚型,并在OSU和ICGC外部队列验证。ANN预测iClusters和分子亚型的准确率分别为75%和82%,整合临床与分子分类的模型预后准确性优于标准分期系统。

要点

  • ANN预测肝胰胆癌分子亚型准确率82%,iClusters准确率75%。
  • 整合临床与分子分类的模型预后准确性优于标准分期系统。
  • 基因状态分析有助于筛选适合靶向治疗的患者。

核心结论

  • 肝胰胆癌的基因状态分析可预测TCGA提出的分类并帮助筛选靶向治疗患者。
  • 整合临床信息与分子分类可提高肝胰胆癌预后预测能力。

研究设计与样本

  • 使用TCGA患者全外显子测序数据训练ANN预测解剖部位、iClusters和分子亚型。
  • OSU和ICGC肝胰胆癌患者作为外部验证队列,TCGA、OSU和ICGC数据合并进行生存分析。

主要发现

  • ANN预测肿瘤解剖部位在TCGA测试队列中准确率低。
  • ANN预测iClusters和分子亚型在TCGA测试队列中准确率分别为75%和82%。
  • 随机生存森林和Cox多变量模型显示整合临床与分子分类的模型预后准确性优于标准分期系统。

临床怎么用

  • 对肝胰胆癌患者进行基因状态分析(如WES、基因panel)以预测TCGA分类。
  • 将分子分类与临床信息整合用于预后评估和靶向治疗患者筛选。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Several multi-omics classifications have been proposed for hepato-pancreato-biliary (HPB) cancers, but these classifications have not proven their role in the clinical practice and been validated in external cohorts. PATIENTS AND METHODS: Data from whole-exome sequencing (WES) of The Cancer Genome Atlas (TCGA) patients were used as an input for the artificial neural network (ANN) to predict the anatomical site, iClusters (cell-of-origin patterns) and molecular subtype classifications. The Ohio State University (OSU) and the International Cancer Genome Consortium (ICGC) patients with HPB cancer were included in external validation cohorts. TCGA, OSU and ICGC data were merged, and survival analyses were performed using both the 'classic' survival analysis and a machine learning algorithm (random survival forest). RESULTS: Although the ANN predicting the anatomical site of the tumour (i.e. cholangiocarcinoma, hepatocellular carcinoma of the liver, pancreatic ductal adenocarcinoma) demonstrated a low accuracy in TCGA test cohort, the ANNs predicting the iClusters (cell-of-origin patterns) and molecular subtype classifications demonstrated a good accuracy of 75% and 82% in TCGA test cohort, respectively. The random survival forest analysis and Cox' multivariable survival models demonstrated that models for HPB cancers that integrated clinical data with molecular classifications (iClusters, molecular subtypes) had an increased prognostic accuracy compared with standard staging systems. CONCLUSION: The analyses of genetic status (i.e. WES, gene panels) of patients with HPB cancers might predict the classifications proposed by TCGA project and help to select patients suitable to targeted therapies. The molecular classifications of HPB cancers when integrated with clinical information could improve the ability to predict the prognosis of patients with HPB cancer.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Bagante F, Spolverato G, Ruzzenente A, et al. Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data. Eur J Cancer. 2021. PMID: 33774439. doi:10.1016/j.ejca.2021.01.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。